These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38624819)

  • 1. Proposal for a NIS directive 2.0: companies covered by the extended scope of application and their obligations.
    Sievers T
    Int Cybersecur Law Rev; 2021; 2(2):223-231. PubMed ID: 38624819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One step ahead: mapping the Italian and German cybersecurity laws against the proposal for a NIS2 directive.
    Schmitz-Berndt S; Chiara PG
    Int Cybersecur Law Rev; 2022; 3(2):289-311. PubMed ID: 37520589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cybersecurity of medical devices: new challenges arising from the AI Act and NIS 2 Directive proposals.
    Biasin E; Kamenjašević E
    Int Cybersecur Law Rev; 2022; 3(1):163-180. PubMed ID: 37521510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitigation of CO2 emissions from the EU-15 building stock: beyond the EU Directive on the Energy Performance of Buildings.
    Petersdorff C; Boermans T; Harnisch J
    Environ Sci Pollut Res Int; 2006 Sep; 13(5):350-8. PubMed ID: 17067030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Corporate Capital Structure on Financial Performance Based on Convolutional Neural Network.
    Luo Y; Jiang C
    Comput Intell Neurosci; 2022; 2022():5895560. PubMed ID: 35515502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigating the maze of requirements for obtaining approval of non-interventional studies (NIS) in the European Union.
    Ramirez I
    Ger Med Sci; 2015; 13():Doc21. PubMed ID: 26633964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Canada's proposed
    Malone M; Walton R
    Int Cybersecur Law Rev; 2023; 4(2):165-196. PubMed ID: 37153843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Communication and the Pharmaceutical Industry: what is the reality?
    Edwards B; Chakraborty S
    Drug Saf; 2012 Nov; 35(11):1027-40. PubMed ID: 23061779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Proposal for a Directive on Defective Products: A Game Changer for Innovative Medicinal Products.
    Guerriaud M; Siranyan V
    Eur J Health Law; 2024 Jan; 31(1):95-109. PubMed ID: 38272064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-indigenous species refined national baseline inventories: A synthesis in the context of the European Union's Marine Strategy Framework Directive.
    Tsiamis K; Palialexis A; Stefanova K; Gladan ŽN; Skejić S; Despalatović M; Cvitković I; Dragičević B; Dulčić J; Vidjak O; Bojanić N; Žuljević A; Aplikioti M; Argyrou M; Josephides M; Michailidis N; Jakobsen HH; Staehr PA; Ojaveer H; Lehtiniemi M; Massé C; Zenetos A; Castriota L; Livi S; Mazziotti C; Schembri PJ; Evans J; Bartolo AG; Kabuta SH; Smolders S; Knegtering E; Gittenberger A; Gruszka P; Kraśniewski W; Bartilotti C; Tuaty-Guerra M; Canning-Clode J; Costa AC; Parente MI; Botelho AZ; Micael J; Miodonski JV; Carreira GP; Lopes V; Chainho P; Barberá C; Naddafi R; Florin AB; Barry P; Stebbing PD; Cardoso AC
    Mar Pollut Bull; 2019 Aug; 145():429-435. PubMed ID: 31590807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Directive 2013/11/EU on Consumer ADR Quality: Evidence from France and the UK.
    Biard A
    J Consum Policy (Dordr); 2019; 42(1):109-147. PubMed ID: 31564762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulations applicable to plant food supplements and related products in the European Union.
    Silano V; Coppens P; Larrañaga-Guetaria A; Minghetti P; Roth-Ehrang R
    Food Funct; 2011 Dec; 2(12):710-9. PubMed ID: 21997496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients?
    Atzor S; Gokhale S; Doherty M
    Pharmaceut Med; 2013 Apr; 27(2):75-82. PubMed ID: 23585715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced graphene oxide decorated with octahedral NiS
    Lu M; Gao N; Zhang XJ; Wang GS
    RSC Adv; 2019 Feb; 9(10):5550-5556. PubMed ID: 35515903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of NiS2 and α-NiS hollow spheres for supercapacitors, non-enzymatic glucose sensors and water treatment.
    Wei C; Cheng C; Cheng Y; Wang Y; Xu Y; Du W; Pang H
    Dalton Trans; 2015 Oct; 44(39):17278-85. PubMed ID: 26379066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Inhibitory Effect of the Deregulation Short-Sale on Private Equity Placement.
    Wang P; Su C; Xu B
    Front Psychol; 2022; 13():888805. PubMed ID: 35903744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital Medical Information Services Delivered by Pharmaceutical Companies via WeChat: Qualitative Analytical Study.
    Ge Y; Yao D; Ung COL; Xue Y; Li M; Lin J; Hu H; Lai Y
    J Med Internet Res; 2023 Nov; 25():e43812. PubMed ID: 37976079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EU Water Framework Directive and Stockholm Convention: can we reach the targets for priority substances and persistent organic pollutants?
    Fuerhacker M
    Environ Sci Pollut Res Int; 2009 Aug; 16 Suppl 1():S92-7. PubMed ID: 19337768
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.